openPR Logo
Press release

Charter Tax Supports Movember

12-22-2017 04:31 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Charter Tax

Charter Tax

Charter Tax

Kent Accountancy firm, Charter Tax, raise money for the Prostate Cancer UK

• Kent based tax specialists raise money for Prostate Cancer UK
• Prostate cancer diagnosis fuelled fundraising efforts
• Movember aims to reduce premature deaths among men by 25%

Employees at Kent-based tax specialists, Charter Tax, have shown their support for this year’s Movember, with 10 team members giving up the razors and growing weird and wonderful moustaches to aid their chosen charity Prostate Cancer UK.

The decision to support the cause was taken following a member of staff’s diagnosis with prostate cancer. Two younger employees chose to show him support by taking part in the event, and other male members of the firm followed suit.

Mark Howard, chairman of Charter Tax said“Charter Tax was pleased to take part in Movember and delighted to raise almost £3,000 for Prostate Cancer UK. The variety of moustaches produced in 30 days was truly astonishing. “1st December could not come fast enough” Mark Howard (now completely clean-shaven) was heard to exclaim. Our thoughts now turn to our colleague and we all wish him a safe and swift return to the office in the New Year.”
Movember is an annual event that involves the growing of moustaches, among other activities, to raise awareness of men’s health issues including prostate cancer, testicular cancer and men’s suicide. The charity aims to reduce the number of premature deaths among men by 25% in the next 12 years.

Many workplaces across the UK hold competitions for the best ‘mo’ as a way of encouraging staff to take part. Charter Tax’s own vote for the best moustache saw the employee diagnosed with cancer take the title this year.

About Charter Tax

Charter Tax was established in 2009 by renowned tax expert, Janet Paterson, and Mike Cordwell, with Mark Howard joining the company in 2015. The firm has rapidly established itself as a niche player in the Tax Advisory and Private Client sectors with its can-do attitude and highly qualified team of professionals.

From its offices in Central London and in Kent, Charter Tax offers a full range of accountancy services tailored to your individual needs. Discover more about Charter Tax at

Charter Tax, Suite 1 Bedgebury Business Park, Forge Farm, Goudhurst, Kent, TN17 2QZ

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Charter Tax Supports Movember here

News-ID: 873446 • Views:

More Releases from Charter Tax

Charter Tax becomes a Xero partner
Charter Tax becomes a Xero partner
Kent and London accountancy firm becomes a Xero Partner • Kent accounting firm is now a Xero partner • Chairman ‘proud’ to offer clients a cutting edge cloud accounting service • Benefits include real-time figures and faster transactions Kent based Chartered Account, Charter Tax, has become an official Xero partner this month. The move represents a step forward for the firm in terms of its technological ability, and acknowledges the change in dynamic of the accounting industry. SME’s
Charter Tax bids farewell to Charter “its Herd of the Hospice?” horse
Charter Tax bids farewell to Charter “its Herd of the Hospice?” horse
Kent Accountancy firm, Charter Tax, raised over £100,000 for Hospice in the Weald • Kent tax experts pleased to have been a part of “Herd of the Hospice?” campaign • ‘Charter’ horse sculpture auctioned to raise further funds for Hospice in the Weald • Over £100,000 raised during the campaign Following the success of the “Herd of the Hospice?” campaign, Charter Tax Consulting Ltd is bidding a fond farewell to the horse sculpture that it sponsored. The horse,
Kent Accountancy Firm Brave Tough Mudder 2017 for Charity
Kent Accountancy Firm Brave Tough Mudder 2017 for Charity
Charter Tax Enter this Years Tough Mudder • South East tax accounting experts brave Tough Mudder challenge for charity • Crawley-based event will see ten team members tackling obstacles and woodland trails • Chairman “full of admiration” for participants Employees at London and Kent-based accountancy firm, Charter Tax Consulting Ltd, will be taking part in the Tough Mudder challenge to raise money for worthy causes. Taking place near Crawley on Saturday 16 September, the event will see
Charter Tax Sponsors “Herd of the Hospice?”
Kent Accountancy Firm Helps Raise Awareness of Local Charity • South East tax experts sponsor local charity initiative, “Herd of the Hospice?” • Teamed up with local artist to decorate horse sculpture in Tunbridge Wells • “Delighted to support the hospice in this novel and creative initiative.” Goudhurst based accountancy firm, Charter Tax Consulting Ltd, is supporting a local charity by sponsoring the decoration of a sculpture in Kent. The charity, Hospice in the Weald, launched its

All 5 Releases

More Releases for Prostate

Prostate 911 Reviews 2021: ( Unrevealed truth) Prostate 911 100% Risk free SCAM …
Benign prostatic hyperplasia is a frequent condition that most guys have to deal with as they get older. Your prostate gland will grow to the measurement of a lemon. It will block the bladder, which will disrupt urine flow. It will motive damage to the urinary tract. It will purpose erectile dysfunction, bladder infection, and kidney problems. More than 50% of men go through from BPH between the age of
Global Prostate Cancer Therapeutics Market
Global Prostate Cancer Therapeutics Market – Industry Analysis and Forecast (2018-2026) –By Product Type, End User, and Region. Global Prostate Cancer Therapeutics Market was valued at US$ 9.21 Bn in 2017 and is expected to reach US$ 16.21 Bn by 2026, at a CAGR of 7.33 % during a forecast period. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data,
Prostate Cancer Therapeutics Market: Future Perspective Growth In Prostate Cance …
Global Prostate Cancer Therapeutics Market Precision Business Insights (PBI) in its report titled “Global Prostate Cancer Therapeutics Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2027” assesses the market performance over 2018-2027. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Prostate Cancer Therapeutics Market Prostate is an exocrine
Prostate Biopsy Forceps Market
Global Prostate Biopsy Forceps Market Status and Trend Report offers a comprehensive analysis on Prostate Biopsy Forceps industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Browse Full Report with TOC: Key questions answered by this report include: Worldwide and Regional Market Size of Prostate Biopsy Forceps 2013-2017,
Prostate Cancer - Pipeline Review, H1 2017
Report Hive Market Research Released a New Research Report of 1845 pages on Title " Prostate Cancer - Pipeline Review, H1 2017 "with detailed Analysis, Forecast and Strategies. Prostate Cancer - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Prostate Cancer - Pipeline Review, H1 2017, provides an overview of the Prostate Cancer (Oncology) pipeline landscape. Prostate cancer is a form of cancer that affects men and
US Prostate Cancer Drug Pipeline Analysis
Prostate cancer has emerged as one of the most commonly diagnosed cancer among men in the US. According to the American Cancer Society, there were close to 242,000 new cases of prostate cancer in the US in 2012, with 28,000 men dying from it. This was an increase from 206,640 men diagnosed with the condition during 2009. The number of men being actively treated for prostrate disorders such as benign